The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs

The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs

ABSTRACT Influenza viruses (IVs) threaten global human health due to the high morbidity, infection, and mortality rates. Currently, the influenza drugs recommended by the FDA are oseltamivir, zanamivir, peramivir, and baloxavir marboxil. Notably, owing to the high variability of IVs, no drug exists...

Full description

Bibliographic Details
Main Authors: Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
Format: Article
Language:English
Published: American Society for Microbiology 2023-10-01
Series:mBio
Subjects:
influenza virus
antiviral drugs
mechanism of action
clinical drugs
adverse event
Online Access:https://journals.asm.org/doi/10.1128/mbio.01273-23

Internet

https://journals.asm.org/doi/10.1128/mbio.01273-23

Similar Items